Ireland offers an ecosystem that encompasses innovation, focuses on talent, and is committed to supporting client sustainability and digital transformation. The MedTech sector in Ireland is going from strength to strength. New centres of excellence such as Digital Manufacturing Ireland, have been established by the Irish Government to assist Irish-based manufacturers in rapidly adopting digital technologies to transform their value chains. MedTech exports from Ireland are worth more than €13bn a year – 8% of the country’s total exports. Ireland’s talent pool, collaboration amongst research centres and universities, as well as connectivity to Europe are some of the key reasons why industry-leaders such as Dexcom, MeiraGTx and Regeneron have come to Ireland. Learn more here: https://lnkd.in/e7sZRb_6 #InvestInIreland #InvestInExtraordinary #MedTech #Innovation #Talent
IDA Ireland’s Post
More Relevant Posts
-
The value of FDI companies in Ireland is significant, not only to GDP but also to the effect on the ecosystem and the positive impact it has on our SMEs in the value chain. Talent and upskilling is a key part of Ireland’s value proposition to attracting and retaining FDI and we need to continue our high quality digital and sustainable skills provision across the skills ecosystem. #upskilling #collaboration #partnership #digitalisation #sustainability #competitiveadvantage
Ireland offers an ecosystem that encompasses innovation, focuses on talent, and is committed to supporting client sustainability and digital transformation. The MedTech sector in Ireland is going from strength to strength. New centres of excellence such as Digital Manufacturing Ireland, have been established by the Irish Government to assist Irish-based manufacturers in rapidly adopting digital technologies to transform their value chains. MedTech exports from Ireland are worth more than €13bn a year – 8% of the country’s total exports. Ireland’s talent pool, collaboration amongst research centres and universities, as well as connectivity to Europe are some of the key reasons why industry-leaders such as Dexcom, MeiraGTx and Regeneron have come to Ireland. Learn more here: https://lnkd.in/e7sZRb_6 #InvestInIreland #InvestInExtraordinary #MedTech #Innovation #Talent
To view or add a comment, sign in
-
Ireland – The Jewel in the Life Sciences Crown? Ireland's life sciences industry is thriving, with over 300 medtech companies and annual exports exceeding €13bn. Key factors driving this growth include a low corporate tax rate, a skilled workforce, and EU access. Recent highlights: - DexCom's €300m investment in Galway, creating up to 1,000 high-skilled jobs. - Ireland hosts 14 of the top 15 global medtech companies. John Nugent from IDA Ireland emphasizes the country’s focus on talent, global connectivity, and sustainability, with 25 green projects approved in 2023. Ireland remains a top destination for medtech innovation and investment. Read full article here: https://lnkd.in/e9BcNF3C #LifeSciences #MedTech #Ireland #FDI #Innovation #Sustainability
To view or add a comment, sign in
-
Have you ever wondered about the origins of the medical technology used in your care? It's important to be informed. Let's ask our healthcare providers what percentage of the medtech used on our bodies is based on American hardware. Knowledge empowers better choices! Here are some effective hashtags for medtech and life sciences:#MedTech #LifeSciences #Biotech #HealthcareInnovation #MedicalTechnology #HealthTech #BioTechInnovation #MedicalDevices #FutureOfMedicine #HealthInnovation #ClinicalResearch #Biotechnology #Pharma #DigitalHealth #MedTechIndustry
To view or add a comment, sign in
-
🇨🇭 Switzerland excels in life sciences, attracting global talent and capital. Top pharma, biotech, and medtech companies like Biogen, Organon, #Novartis, and #Roche thrive, alongside many smaller firms. This vibrant ecosystem fosters innovation and partnerships. Swiss life science: a global powerhouse - 1,400 manufacturers and service providers - 110 billion CHF in exports - 114,510 employees - 3,124 companies MedDevice/Digital Health: leading innovation Switzerland is a prime destination for MedDevice and digital health, boasting the highest number of medtech companies per resident in Europe. Key strengths include: Strong research and skilled workforce Supportive regulatory environment Access to capital and strategic partnerships Switzerland’s biotech powerhouse Driven by renowned academic institutions, proximity to biopharma, robust IP protection, and political stability, Switzerland offers an outstanding environment for health tech innovation. Discover more of the advantages of Switzerland for the future of health: https://lnkd.in/dRbTFcfg #LifeScience #DigitalHealth #Switzerland #MedTech
To view or add a comment, sign in
-
-
🚫 Myth: Medtech trials in Latin America are inefficient and complex. Reality: It's a misconception that hinders progress. While challenges exist, there are solutions. Language barriers and fragmented resources can be overcome with the right partners, such as bioaccess®. They specialize in supporting Medtech startups by streamlining early feasibility clinical trials in Latin America. This collaboration can accelerate innovation and execution, bridging the gap for US companies. 🌟 Let's rethink the narrative and explore opportunities in Latin America for Medtech advancements. 🌎 #Medtech #ClinicalTrials https://lnkd.in/eJg3R9Xs
To view or add a comment, sign in
-
With over 450 companies (including nine of the world’s top ten MedTech giants), 50,000+ people employed and exports valued at €16bn, Ireland is recognised as one of the top five global #MedTech hubs. In this article, #Galway partner and member of the Forvis Mazars Group life sciences board, Austin Sammon, reviews Ireland’s life sciences and MedTech sector and the key drivers of the industry’s innovation and R&D ecosystem. https://lnkd.in/eEMYWv59
To view or add a comment, sign in
-
🔍 Exploring Chile's Medtech Clinical Trial Boom: Key Drivers 🚀 1. Regulatory Speed: Chile's fast approval process is a game changer for medtech companies eager to start trials quickly. 2. Robust Healthcare System: With universal coverage and advanced facilities, Chile provides a fertile ground for high-quality trials. 3. Diverse Patient Pool: A varied population ensures comprehensive trial results. 4. Skilled Professionals: Expert researchers familiar with international standards boost trial quality. 5. Cost-Effectiveness: Conducting trials in Chile is budget-friendly, making it an attractive option for medtech startups. Chile is not just participating in the medtech landscape; it's leading the way in Latin America. For deeper insights, consider scheduling a Medtech Clinical Trial Consult with bioaccess®. 🌐 #Medtech #ClinicalTrials https://lnkd.in/g_a4ty5e
To view or add a comment, sign in
-
The medical device landscape is evolving, and Latin America is at the forefront of this transformation. Velocity Clinical Research's strategic expansion into the region highlights a significant trend: the consolidation of clinical research sites. Why is this important? For Medtech startups eager to accelerate their paths to market, understanding this trend is crucial. Here's why Latin America should be on your radar: → Growing Infrastructure: ↳ Investment in clinical research infrastructure is increasing, making it easier to conduct efficient trials. → Strategic Location: ↳ Proximity to the U.S. provides logistical advantages, reducing time and cost. → Opportunities for Growth: ↳ The demand for innovative medical devices is rising, and early movers can capture significant market share. At bioaccess®, we're uniquely positioned to help Medtech companies navigate these opportunities. With over 15 years of experience in the region, we offer: → Tailored Clinical Trial Services: ↳ From pilot studies to fullscale trials, we ensure highquality outcomes. → Regulatory Expertise: ↳ Our team understands the nuances of local regulations, minimizing potential hurdles. → CostEffective Solutions: ↳ We help you maximize your budget without compromising on quality. Are you ready to explore the potential of Latin America for your clinical trials? Connect with us at bioaccess® and let's discuss how we can support your journey. Your next breakthrough could be closer than you think.
To view or add a comment, sign in
-
🔍 Exploring Chile's Medtech Clinical Trial Boom: Key Drivers 🚀 1. Regulatory Speed: Chile's fast approval process is a game changer for medtech companies eager to start trials quickly. 2. Robust Healthcare System: With universal coverage and advanced facilities, Chile provides a fertile ground for high-quality trials. 3. Diverse Patient Pool: A varied population ensures comprehensive trial results. 4. Skilled Professionals: Expert researchers familiar with international standards boost trial quality. 5. Cost-Effectiveness: Conducting trials in Chile is budget-friendly, making it an attractive option for medtech startups. Chile is not just participating in the medtech landscape; it's leading the way in Latin America. For deeper insights, consider scheduling a Medtech Clinical Trial Consult with bioaccess®. 🌐 #Medtech #ClinicalTrials https://lnkd.in/g_a4ty5e
To view or add a comment, sign in
-
In the Medtech industry, the fragmentation of resources in Latin America presents a significant hurdle for US companies. Many face challenges due to a lack of established Contract Research Organization (CRO) structures, hindering efficient collaboration with local hospitals. This gap affects communication and execution, especially in early clinical trials. bioaccess® steps in as a solution, offering robust CRO services that help medtech startups navigate these complexities. By facilitating early feasibility trials in Latin America, bioaccess® bridges the gap, ensuring smoother operations and successful outcomes. The path to innovation doesn't have to be daunting when you have the right support. 🌟 #Medtech #ClinicalTrials https://lnkd.in/eJg3R9Xs
To view or add a comment, sign in